Drug Type ASO |
Synonyms- |
Target |
Action inhibitors |
Mechanism SYNGAP1 inhibitors(Ras GTPase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Brain Diseases | Discovery | United States | 19 Apr 2024 | |
Dystonic Disorders | Discovery | United States | 19 Apr 2024 | |
Intellectual Disability | Discovery | United States | 19 Apr 2024 |